Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 1141 - 1150 of 2501
  • 2021 CAREER Award recipient: Alex Hughes

    The assistant professor in bioengineering and in cell and developmental biology, is among the Penn Engineering faculty members who have received the CAREER Award this year. Hughes plans to use the funds to develop a human kidney model to better understand how the development of cells and tissues influences congenital diseases of the kidney and urinary tract.

    FULL STORY AT Penn Engineering Today

  • Penn’s Department of Cell and Developmental Biology—Insights on scientific excellence from a female powerhouse

    This spring, the National Academy of Sciences, a 158-year-old nonprofit organization that promotes scientific excellence and advises the United States government and public on the latest scientific developments, elected two scientists to its membership from the department of Cell and Developmental Biology in the Perelman School of Medicine. M. Celeste Simon, the Arthur H. Rubenstein, MBBCh Professor and the scientific director of the Abramson Family Cancer Research Institute, and Marisa S.

    FULL STORY AT Penn Medicine News

  • PJ Brennan named to Delaware County Board of Health

    The chief medical officer and SVP of Penn Medicine, has been chosen as one of the five members on the newly created Delaware County Board of Health.

    FULL STORY AT Penn Medicine News

  • Back to health care’s other big challenges: Return of the Innovation Accelerator

    The Accelerator is an annual fixture of the Center for Health Care Innovation, but there was no class in 2020. Most of the Center’s staff had been dispatched on various projects to battle COVID-19. So the fact that a 2021 class is being selected is a welcoming sign of the approach of normalcy.

    FULL STORY AT Penn Medicine News

  • Featured Books: Pride Month

    To help celebrate Pride Month, staff, students, and faculty of Penn’s LGBT Center have put together a selection of books and films that explore the LGBTQ experience through fiction and nonfiction, both joyful and tragic, written for children, adults, and everyone in between.

    FULL STORY AT Penn Libraries

  • Applauding PPMC’s unsung admin heroes

    Administrative professionals may largely work out of the spotlight, but their efforts ensure that every unit and department is stocked, staffed, and scheduled. Several members of the hospital system’s administrative staff here are highlighted for their dedication.

    FULL STORY AT Penn Medicine News

  • University of Pennsylvania Carey Law School establishes the Morgan Lewis Impact Fund for Racial Justice

    The $250,000 fund will provide financial support to racial justice and anti-racism efforts at the Law School, expanding initiatives to advance racial justice in the classroom, in the community, and in the profession.

    FULL STORY AT Penn Carey Law

  • Penn Medicine CAREs Serve Saturday

    In the Serve Saturday outreaches, volunteers gather in underserved areas in the city to lead a variety of programs, ranging from giving out groceries, paying for gas and offering SEPTA key cards, to cleaning public spaces. With support from a Penn Medicine CAREs grant, Serve Saturday will be able to extend their services to the Port Richmond area in North Philadephia.

    FULL STORY AT Penn Medicine News

  • Michael Kahana leads team awarded $3.4 million to study the treatment of memory loss in patients with traumatic brain injury

    A team of neuroscientists led by Michael Jacob Kahana, Edmund J. and Louise W. Kahn Term Professor of Psychology and and Director of the Computational Memory Lab, are developing and testing new therapeutics for treating memory loss in patients with traumatic brain injury, alongside basic research on electrophysiological biomarkers of memory at Penn.

    FULL STORY AT Penn Arts & Sciences

  • Antibody infusion treatment offers peace of mind for people at high risk for severe illness from COVID-19

    Monoclonal antibodies, laboratory-made proteins that effectively boost the immune system’s ability to fight the COVID-19 virus, is shown to significantly reduce the risk of hospitalization or death in people age 65 or older, and those with certain chronic medical conditions, such as diabetes, heart disease, or obesity. Monoclonal antibody infusion received an emergency use authorization from the U.S. Food and Drug Administration in late 2020, following successful clinical trials at Penn Medicine and other institutions. 

    FULL STORY AT Penn Medicine News